Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
    « Previous Issue | Next Issue »
  Cover Image

Volume 28, Issue 6; June 1, 2008

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

 

EditorialsBack

The Homocysteine Paradox

Roman N. Rodionov and Steven R. Lentz
Arterioscler Thromb Vasc Biol. 2008;28:1031-1033, doi:10.1161/ATVBAHA.108.164830
Full Text | PDF  

"Priming" Endothelial Progenitor Cells: A New Strategy to Improve Cell Based Therapeutics

Geoffrey C. Gurtner and Edwin Chang
Arterioscler Thromb Vasc Biol. 2008;28:1034-1035, doi:10.1161/ATVBAHA.108.163246
Full Text | PDF  

Preventing Stenosis by Local Inhibition of KCa3.1: A Finger on the Phenotypic Switch

Karen M. Lounsbury
Arterioscler Thromb Vasc Biol. 2008;28:1036-1038, doi:10.1161/ATVBAHA.108.164988
Full Text | PDF  

 

Brief ReviewsBack

Jean-Pierre Després, Isabelle Lemieux, Jean Bergeron, Philippe Pibarot, Patrick Mathieu, Eric Larose, Josep Rodés-Cabau, Olivier F. Bertrand, and Paul Poirier
Arterioscler Thromb Vasc Biol. 2008;28:1039-1049; published online before print March 20 2008, doi:10.1161/ATVBAHA.107.159228
Abstract | Full Text | PDF  

Elena Rigamonti, Giulia Chinetti-Gbaguidi, and Bart Staels
Arterioscler Thromb Vasc Biol. 2008;28:1050-1059; published online before print March 6 2008, doi:10.1161/ATVBAHA.107.158998
Abstract | Full Text | PDF  

Maaike Kockx, Wendy Jessup, and Leonard Kritharides
Arterioscler Thromb Vasc Biol. 2008;28:1060-1067; published online before print April 3 2008, doi:10.1161/ATVBAHA.108.164350
Abstract | Full Text | PDF  

 

Integrative Physiology/Experimental MedicineBack

Naoto Sasaki, Tomoya Yamashita, Tomofumi Takaya, Masakazu Shinohara, Rio Shiraki, Masafumi Takeda, Noriaki Emoto, Akiko Fukatsu, Toshio Hayashi, Kazuhisa Ikemoto, Takahide Nomura, Mitsuhiro Yokoyama, Ken-ichi Hirata, and Seinosuke Kawashima
Arterioscler Thromb Vasc Biol. 2008;28:1068-1076; published online before print April 10 2008, doi:10.1161/ATVBAHA.107.160754
Abstract | Full Text | PDF | Data Supplement
In streptozotocin-induced diabetic mice, diabetes accelerated vascular remodeling in association with augmented superoxide production from the uncoupled eNOS. Exogenous tetrahydrobiopterin inhibited the augmentation of remodeling process by restoring eNOS coupling. These findings may provide a new crew to therapeutic strategy for diabetic vascular complication.  

Hironobu Matsumae, Yoshinori Yoshida, Koh Ono, Kiyonori Togi, Katsumi Inoue, Yutaka Furukawa, Yasuhiro Nakashima, Yoji Kojima, Masakiyo Nobuyoshi, Toru Kita, and Makoto Tanaka
Arterioscler Thromb Vasc Biol. 2008;28:1077-1083; published online before print April 3 2008, doi:10.1161/ATVBAHA.108.162362
Abstract | Full Text | PDF | Data Supplement  

D.L. Tharp, B.R. Wamhoff, H. Wulff, G. Raman, A. Cheong, and D.K. Bowles
Arterioscler Thromb Vasc Biol. 2008;28:1084-1089; published online before print February 28 2008, doi:10.1161/ATVBAHA.107.155796
Abstract | Full Text | PDF
The objective of the present study was to determine the role of KCa3.1 in the regulation of coronary smooth muscle cell (SMC) phenotypic modulation in a swine model of postangioplasty restenosis. Blockade of KCa3.1 by delivery of TRAM-34 via balloon catheter prevented SMC phenotypic modulation and limited subsequent restenosis.  

Vincent Braunersreuther, Sabine Steffens, Claire Arnaud, Graziano Pelli, Fabienne Burger, Amanda Proudfoot, and François Mach
Arterioscler Thromb Vasc Biol. 2008;28:1090-1096; published online before print April 3 2008, doi:10.1161/ATVBAHA.108.165423
Abstract | Full Text | PDF | Data Supplement  

Lesca M. Holdt, Joachim Thiery, Jan L. Breslow, and Daniel Teupser
Arterioscler Thromb Vasc Biol. 2008;28:1097-1103; published online before print March 20 2008, doi:10.1161/ATVBAHA.108.165654
Abstract | Full Text | PDF | Data Supplement
In previous work, we have identified an atherosclerosis susceptibility quantitative trait locus (QTL) on mouse chromosome 12 in an F2-intercross of LDL receptor-deficient FVB and C57BL/6 mice. Using expression QTL mapping and functional assays, we identified the metalloproteinase ADAM17 as a candidate gene of atherosclerosis susceptibility at this locus.  

Michael Altenburg, Jose Arbones-Mainar, Lance Johnson, Jennifer Wilder, and Nobuyo Maeda
Arterioscler Thromb Vasc Biol. 2008;28:1104-1110; published online before print March 27 2008, doi:10.1161/ATVBAHA.108.164863
Abstract | Full Text | PDF | Data Supplement
Increased LDLR expression enhances sequestration of apoE4 and VLDL on the hepatocyte surface but delays the internalization of VLDL. In contrast, apoE2, having low LDLR affinity, freely associates with VLDL in circulation and assists internalization when LDLR expression is high. This mechanism may contribute to the lipoprotein profiles associated with apoE isoforms.  

Vandana S. Dole, Jana Matuskova, Eliza Vasile, Ayce Yesilaltay, Wolfgang Bergmeier, Michael Bernimoulin, Denisa D. Wagner, and Monty Krieger
Arterioscler Thromb Vasc Biol. 2008;28:1111-1116; published online before print April 24 2008, doi:10.1161/ATVBAHA.108.162347
Abstract | Full Text | PDF | Data Supplement
The high UC:TC ratio associated with SR-BI deficiency in mice is correlated with platelet abnormalities, including high cholesterol content, abnormal morphologies, high clearance rates, thrombocytopenia, and a minor defect in in vitro aggregation (blunted response to ADP).  

John C. Chappell, Ji Song, Alexander L. Klibanov, and Richard J. Price
Arterioscler Thromb Vasc Biol. 2008;28:1117-1122; published online before print April 10 2008, doi:10.1161/ATVBAHA.108.165589
Abstract | Full Text | PDF | Data Supplement
Ultrasonic microbubble destruction represents a potential tool in therapeutic strategies, particularly in the targeted stimulation of neovascularization. In the current study, we demonstrate the ability of ultrasound-microbubble interactions to enhance arteriogenesis and perfusion in ischemic tissues through recruitment of marrow-derived cells via CD18. These observations support the development of ultrasound microbubble-based therapies.  

Anke C. Webler, Rüdiger Popp, Thomas Korff, U. Ruth Michaelis, Carmen Urbich, Rudi Busse, and Ingrid Fleming
Arterioscler Thromb Vasc Biol. 2008;28:1123-1129; published online before print March 13 2008, doi:10.1161/ATVBAHA.107.161190
Abstract | Full Text | PDF | Data Supplement  

George T. Roberts, Hazem Ghebeh, Muhammad A. Chishti, Falah Al-Mohanna, Rafaat El-Sayed, Futwan Al-Mohanna, and Abderrezak Bouchama
Arterioscler Thromb Vasc Biol. 2008;28:1130-1136; published online before print April 3 2008, doi:10.1161/ATVBAHA.107.158709
Abstract | Full Text | PDF | Data Supplement
Severe heatstroke is a leading cause of morbidity and mortality during heat waves. The pathogenesis of tissue injury and death in heatstroke is not well understood. Using a heatstroke baboon model, we showed that microvascular injury, thrombosis, inflammation, and apoptosis may play an important pathogenic role.  

 

CorrectionsBack

Correction


Arterioscler Thromb Vasc Biol. 2008;28:e150, doi:10.1161/ATVBAHA.107.654321
Full Text | PDF  

 

Cell Biology and SignalingBack

Christian A. Gleissner, John M. Sanders, Jerry Nadler, and Klaus Ley
Arterioscler Thromb Vasc Biol. 2008;28:1137-1143; published online before print May 1 2008, doi:10.1161/ATVBAHA.107.158295
Abstract | Full Text | PDF | Data Supplement
Aldose reductase (AR) is the rate-limiting enzyme of the polyol pathway, which is linked to microvascular complications in diabetes. Upregulation of AR gene expression and activity in macrophages during foam cell formation resulted in increased oxidative stress. AR expression in macrophages in human atherosclerotic lesions supports its role in atherogenesis.  

Mireille Ouimet, Ming-Dong Wang, Natalie Cadotte, Kenneth Ho, and Yves L. Marcel
Arterioscler Thromb Vasc Biol. 2008;28:1144-1150; published online before print March 27 2008, doi:10.1161/ATVBAHA.107.157115
Abstract | Full Text | PDF | Data Supplement
We report that in cholesterol-loaded macrophages, epoxycholesterol decreases ABCA1- and ABCG1-mediated cholesterol efflux, despite increasing the expression of both transporters. We show that epoxycholesterol impairs cholesteryl ester hydrolysis activity in macrophage foam cells, thus reducing the availability of cholesterol for efflux to apoA-I and HDL.  

Wendy W. Batenburg, René J.A. de Bruin, Jeanette M.G. van Gool, Dominik N. Müller, Michael Bader, Geneviève Nguyen, and A. H. Jan Danser
Arterioscler Thromb Vasc Biol. 2008;28:1151-1157; published online before print April 3 2008, doi:10.1161/ATVBAHA.108.164210
Abstract | Full Text | PDF
Renin inhibition with aliskiren causes a large rise in renin, potentially leading to angiotensin generation or stimulation of the (pro)renin receptor ((P)RR). This study shows that the renin rise relates to the detection of prorenin as renin and to a decrease in (pro)renin clearance. Aliskiren does not affect (pro)renin-(P)RR binding.  

 

Clinical and Population StudiesBack

Kathleen Potter, Graeme J. Hankey, Daniel J. Green, John W. Eikelboom, and Leonard F. Arnolda
Arterioscler Thromb Vasc Biol. 2008;28:1158-1164; published online before print March 20 2008, doi:10.1161/ATVBAHA.108.162743
Abstract | Full Text | PDF
We tested the effect of adjusting for renal function on the relationship between plasma homocysteine concentrations (tHcy) and carotid intima medial thickness (CIMT) and flow-mediated dilation (FMD) with regression analysis of randomized data from 173 stroke patients. Adjusting for renal function eliminated the association between tHcy and CIMT and FMD.  

Christopher J. O’Donnell, Serkalem Demissie, Masayuki Kimura, Daniel Levy, Jeffery P. Gardner, Charles White, Ralph B. D’Agostino, Philip A. Wolf, Joseph Polak, L. Adrienne Cupples, and Abraham Aviv
Arterioscler Thromb Vasc Biol. 2008;28:1165-1171; published online before print April 3 2008, doi:10.1161/ATVBAHA.107.154849
Abstract | Full Text | PDF  

Sander J. Robins, Dorothea Collins, Jeanenne J. Nelson, Hanna E. Bloomfield, and Bela F. Asztalos
Arterioscler Thromb Vasc Biol. 2008;28:1172-1178; published online before print March 20 2008, doi:10.1161/ATVBAHA.107.160739
Abstract | Full Text | PDF
The phospholipase, Lp-PLA2 is known to be associated with LDL and an increase in cardiovascular events. We show in the VA-HIT population with both low HDL-C and low LDL-C that Lp-PLA2 was significantly increased, independently associated with increased cardiovascular events, and reduced by gemfibrozil therapy.  

Michal L. Melamed, Paul Muntner, Erin D. Michos, Jaime Uribarri, Collin Weber, Jyotirmay Sharma, and Paolo Raggi
Arterioscler Thromb Vasc Biol. 2008;28:1179-1185; published online before print April 16 2008, doi:10.1161/ATVBAHA.108.165886
Abstract | Full Text | PDF Free Article
Vitamin D is an inhibitor of the renin-angiotensin system and has antiinflammatory and anticoagulant properties. Among 4839 NHANES 2001 to 2004 participants, low 25(OH)D levels were associated with a higher prevalence of PAD, after multivariate adjustment. To confirm this association, longitudinal cohort and mechanistic studies are needed.  

Christa Meisinger, Wolfgang Koenig, Jens Baumert, and Angela Döring
Arterioscler Thromb Vasc Biol. 2008;28:1186-1192; published online before print March 20 2008, doi:10.1161/ATVBAHA.107.160184
Abstract | Full Text | PDF
Uric acid levels are associated with CVD mortality and all-cause mortality in middle-aged men from the general population independent of conventional cardiovascular risk factors, C-reactive protein, and diuretic intake. Thus, the measurement of UA may turn out as a useful tool for improved individual cardiovascular risk assessment, in addition to conventional risk factors.  

Rebecca Mar-Heyming, Makoto Miyazaki, Daphna Weissglas-Volkov, Nicholas A. Kolaitis, Narimaan Sadaat, Christopher Plaisier, Päivi Pajukanta, Rita M. Cantor, Tjerk W.A. de Bruin, James M. Ntambi, and Aldons J. Lusis
Arterioscler Thromb Vasc Biol. 2008;28:1193-1199; published online before print March 13 2008, doi:10.1161/ATVBAHA.107.160150
Abstract | Full Text | PDF
We used the fatty acid desaturation index to investigate the relationship of SCD1 to FCHL. The fatty acid desaturation index was elevated in FCHL individuals (P<0.0001). Specific haplotypes of HNF4{alpha} (P=0.002) were modestly associated with the desaturation index.  

Paolo Parini, Ulf Gustafsson, Matt A. Davis, Lilian Larsson, Curt Einarsson, Martha Wilson, Mats Rudling, Hiroshi Tomoda, Satoshi Omura, Staffan Sahlin, Bo Angelin, Lawrence L. Rudel, and Mats Eriksson
Arterioscler Thromb Vasc Biol. 2008;28:1200-1206; published online before print March 13 2008, doi:10.1161/ATVBAHA.107.157172
Abstract | Full Text | PDF | Data Supplement
Thirty-seven normocholesterolemic gallstone patients randomized to placebo, 20 mg/d fluvastatin, or 80 mg/d atorvastatin for 4 weeks were studied. Cholesterol synthesis in liver was reduced by 42% and 70% in the 2 groups receiving statins. Associated decreases in VLDL cholesterol of 20% and 55%, respectively, were shown. The activity, protein, and mRNA for hepatic ACAT2 were decreased in response to statins as was apoE mRNA.  

 

Abstracts of the Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference 2008Back

2008 ATVB Oral Presentations


Arterioscler Thromb Vasc Biol. 2008;28:e32-e149, doi:10.1161/01.ATV.0000319737.80976.26
PDF  

Spotlight

TOC Spotlight File Banner1TOCpage

Banner2TOCpage